Skip to content

Comparing between Ketamine and Fentanyl while providing Anaesthesia in minor surgeries

Comparative evaluation of Ketamine and Fentanyl as pre-induction agent with Propofol on haemodynamic stability and recovery characteristics in minor surgical procedures

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025793
Enrollment
82
Registered
2020-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified Health Condition 2: N751- Abscess of Bartholins gland Health Condition 3: M674- Ganglion Health Condition 4: M654- Radial styloid tenosynovitis [de Quervain] Health Condition 5: M653- Trigger finger Health Condition 6: N959- Unspecified menopausal and perimenopausal disorder

Interventions

Control Intervention1: Ketamine 0.5mg/kg Propofol 2mg/kg: Ketamine - Pre induction agent Propofol - Induction agent Control Intervention2: Fentanyl - 1.5 micro gram/kg. Propofol - 2mg/kg: Fentanyl - p

Sponsors

Nithin Boban
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I and II Patients undergoing short surgical procedure

Exclusion criteria

Exclusion criteria: Patient consent not obtained. Any active respiratory tract infections. Patients who received any analgesic or narcotic in the preceding 48hrs. Patients with psychiatric disorders and substance abuse. Hypersensitivity to anaesthetic drug.

Design outcomes

Primary

MeasureTime frame
Pulse rate Systolic blood pressure Diastolic blood pressure Mean arterial pressure Spo2 Timepoint: 1,3,5,10,15,20 min following induction.

Secondary

MeasureTime frame
Modified Aldrete Scoring SystemTimepoint: every 15 minutes after recovery till score becomes 9/10.

Countries

India

Contacts

Public ContactDr Nithin Boban

Pushpagiri Institute of Medical Science and Research Center

doctorthomaspgeorge@gmail.com9447409620

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026